Gabrail Cancer & Research Center
Skip to content
  • For Patients
    • New Patients
      • Request An Appointment
      • Referrals
    • What to expect?
      • Symptom Management
    • Patient Testimonials
    • Satisfaction Survey
  • Our Services
    • Clinical Trials
      • Clinical Research Trials (CRT)
    • Infusion Therapy
    • Instant Imaging
    • On Site Lab Services
    • The Liberty Pharmacy
    • Family Cancer Registry
    • Community Outreach
  • Clinical Trials
    • Clinical Trials at GCC
    • About Clinical Trials
      • Clinical Trial Phases
    • For Sponsors
      • Sponsor Testimonials
    • Approved Oncology Drugs
  • About Us
    • Physicians
    • Our Staff
    • Mission Statement
    • Location
    • Careers
  • Media
    • Podcasts
      • The Cancer Gene
      • Good Medicine Is Cheaper Medicine
    • Radio
    • TV
    • Articles
August 15, 2016 gabrailcancercenter

Leukemia

The Gabrail Cancer Center currently has many Clinical Trial opportunities . For more information and to see if you qualify call Carrie Smith R.N., Director of Research at 330-492-3345 x 208 or email CSmith@GabrailCancerCenter.com.

An open label Phase Ia/b dose escalation followed by dose expansion safety and tolerability trial of CAP-100, a humanized C-C-chemokine receptor 7 antibody, administered as monotherapy in subjects with r/r chronic lymphocytic leukemia.

Delta Fly D18-11141: Phase III Randomized Trial of DFP-10917 vs. Non-Intensive Reinduction (LoDAC, Azacitidine, Decitabine, Venetoclax Combination Regimens) or Intensive Reinduction (High and Intermediate Dose Cytarabine Regimens) for Acute Myelogenous Leukemia Patients in Second, Third, or Fourth Salvage

A phase IB/II study of APG-2575 as a single agent or in combination with other therapeutics agents in patients with relapsed and/or refactory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (SACRED)

A phase 1B study of the pharmacokinetics, safety and efficacy of orally administered HQP1351 in subjects with refactory Chronic Myeloid Leukemia (CML)

Return to Clinical Trials at GCC

Archives

  • May 2019
  • October 2016
  • August 2016
  • July 2015
  • May 2013

Meta

  • Log in

Subscribe to Podcast

4875 Higbee Ave NW Canton, OH 44718
cantondesk@gabrailcancercenter.com
330-492-3345
  • Facebook link
  • Instagram link
Zerif Lite developed by ThemeIsle
This website uses cookies to improve your experience. We'll assume you accept this policy as long as you are using this websiteAcceptView Policy